Treating ADHD in adults

Photo of a woman reading a package insert

The most appropriate treatment for adults with attention deficit hyperactivity disorder (ADHD) will largely depend on their individual circumstances and the type of problems being caused by the condition.

Most adults who have ADHD develop their own strategies for dealing with the disorder. Some may try using relaxation techniques or turn to support groups for help, while others may find doing sports helpful.

Some adults with ADHD need more help to successfully cope with their disorder. In their case, medication and/or psychotherapy may be good treatment options. Medication can effectively reduce the main ADHD symptoms of hyperactivity, impulsiveness and inattentiveness. Behavioral therapy can help you learn different ways to better cope with behavioral problems and the effects they have in everyday life.

How does ADHD medication work?

The medicines most commonly used to treat ADHD usually contain the drug methylphenidate (found in medicines like “Medikinet adult” or “Ritalin adult”). One of the things these medicines do is increase the levels of the chemical messengers dopamine and noradrenaline in the brain. These two chemicals carry information between nerve cells and play an important role in our memory formation and learning processes. For instance, they help the brain filter information from the outside world. This helps to improve concentration and focus better. Treatment with lisdexamfetamine (trade name: Elvanse or Vyvanse) is possible, too – as long as the treatment was started before the age of 18.

If these medications don’t help, atomoxetine (Strattera) is an alternative option. Atomoxetine works in a different way, but it also increases levels of noradrenaline in the brain.

Can medication help adults who have ADHD?

Research has suggested that methylphenidate can improve concentration and reduce hyperactivity and impulsiveness in adults as well. There is less good-quality research on the medication in adults than in children and teenagers, though. The studies were small, and the participants were only observed for a few weeks. The side effects of methylphenidate include loss of appetite, weight loss and insomnia.

If treatment with methylphenidate isn't effective, atomoxetine is an option. The potential side effects of atomoxetine include loss of appetite, a dry mouth and insomnia. It can also cause erection problems or loss of interest in sex.

ADHD drugs can sometimes increase both blood pressure and heart rate. For this reason, doctors will check your heart before prescribing any medication.

ADHD medication is usually only prescribed by suitably qualified doctors. These include psychiatrists, specialists for psychosomatic medicine, psychotherapists or neurologists. Medication should only be prescribed as part of a more comprehensive therapy approach that may include psychological treatment.

When might psychological treatment help?

Psychological treatment such as behavioral therapy can help with mental or emotional problems that medication can't do anything about. It might also be an alternative option if medication doesn't work or you would prefer not to take it. It can be helpful for people who are diagnosed with ADHD as adults and are struggling to better understand and cope with the disorder. And it can be a good idea for people who have other mental health problems too, such as depression or anxiety disorders.

There are fewer studies on the benefits of psychological treatment in adults with ADHD than there are on the benefits of medication in adults with ADHD. The available studies suggest that psychological treatment can be effective, though. But not many psychotherapists in Germany have specialized in ADHD in adults. And it may take several weeks or even months to get an appointment.

There is currently no good-quality research on treatments for adults other than medication and psychological treatment.

Canadian Agency for Drugs and Technologies in Health (CADTH). Pharmacological and non-pharmacological therapies for adults with attention-deficit / hyperactivity disorder: systematic review and meta-analysis of clinical evidence. 2011.

Castells X, Blanco‐Silvente L, Cunill R. Amphetamines for attention deficit hyperactivity disorder (ADHD) in adults. Cochrane Database Syst Rev 2018; (8): CD007813.

Deutsche Gesellschaft für Kinder- und Jugendpsychiatrie, Psychosomatik und Psychotherapie (DGKJP), Deutsche Gesellschaft für Psychiatrie und Psychotherapie, Psychosomatik und Nervenheilkunde (DGPPN), Deutsche Gesellschaft für Sozialpädiatrie und Jugendmedizin (DGSPJ). Langfassung der interdisziplinären evidenz- und konsensbasierten (S3) Leitlinie "Aufmerksamkeitsdefizit- / Hyperaktivitätsstörung (ADHS) im Kindes-, Jugend- und Erwachsenenalter" (in Überarbeitung, gültig bis 01.05.2022). AWMF-Registernr.: 028-045. 2018.

Elliott J, Johnston A, Husereau D et al. Pharmacologic treatment of attention deficit hyperactivity disorder in adults: A systematic review and network meta-analysis. PLoS One 2020; 15(10): e0240584.

Scholz L, Werle J, Philipsen A et al. Effects and feasibility of psychological interventions to reduce inattention symptoms in adults with ADHD: a systematic review. J Ment Health 2020 [Epub ahead of print]: 1-14.

IQWiG health information is written with the aim of helping people understand the advantages and disadvantages of the main treatment options and health care services.

Because IQWiG is a German institute, some of the information provided here is specific to the German health care system. The suitability of any of the described options in an individual case can be determined by talking to a doctor. informedhealth.org can provide support for talks with doctors and other medical professionals, but cannot replace them. We do not offer individual consultations.

Our information is based on the results of good-quality studies. It is written by a team of health care professionals, scientists and editors, and reviewed by external experts. You can find a detailed description of how our health information is produced and updated in our methods.

Comment on this page

What would you like to share with us?

We welcome any feedback and ideas - either via our form or by gi-kontakt@iqwig.de. We will review, but not publish, your ratings and comments. Your information will of course be treated confidentially. Fields marked with an asterisk (*) are required fields.

Please note that we do not provide individual advice on matters of health. You can read about where to find help and support in Germany in our information “How can I find self-help groups and information centers?

Über diese Seite

Updated on June 21, 2022

Next planned update: 2025

Publisher:

Institute for Quality and Efficiency in Health Care (IQWiG, Germany)

How we keep you informed

Follow us on Twitter or subscribe to our newsletter or newsfeed. You can find all of our films online on YouTube.